Drug Profile
ORG 43902
Latest Information Update: 27 Feb 2015
Price :
$50
*
At a glance
- Originator Organon
- Developer Merck Sharp & Dohme
- Class Infertility therapies; Small molecules
- Mechanism of Action LHRH receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Female infertility